Drugs Improving Insulin Resistance for Non-Alcoholic Fatty Liver Disease And/or Non-Alcoholic Steatohepatitis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of drugs improving insulin resistance for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis.